Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Cash from Investing Activities (2020 - 2023)

Journey Medical filings provide 4 years of Cash from Investing Activities readings, the most recent being -$5.0 million for Q1 2023.

  • On a quarterly basis, Cash from Investing Activities rose 75.0% to -$5.0 million in Q1 2023 year-over-year; TTM through Dec 2023 was -$5.0 million, a 75.0% increase, with the full-year FY2024 number at -$15.0 million, down 200.0% from a year prior.
  • Cash from Investing Activities hit -$5.0 million in Q1 2023 for Journey Medical, up from -$20.0 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$200000.0 in Q4 2020 to a low of -$20.0 million in Q1 2022.
  • Median Cash from Investing Activities over the past 4 years was -$3.1 million (2021), compared with a mean of -$6.6 million.
  • Biggest five-year swings in Cash from Investing Activities: crashed 500.0% in 2021 and later soared 75.0% in 2023.
  • Journey Medical's Cash from Investing Activities stood at -$200000.0 in 2020, then crashed by 500.0% to -$1.2 million in 2021, then crashed by 1566.67% to -$20.0 million in 2022, then soared by 75.0% to -$5.0 million in 2023.
  • The last three reported values for Cash from Investing Activities were -$5.0 million (Q1 2023), -$20.0 million (Q1 2022), and -$1.2 million (Q4 2021) per Business Quant data.